Glucocorticoids Inhibit EGFR Signaling Activation in Podocytes in Anti-GBM Crescentic Glomerulonephritis

Glucocorticoids are commonly used to treat anti-GBM crescentic glomerulonephritis, however, the mechanism underlying its therapeutic effectiveness is not completely understood. Since podocyte EGFR/STAT3 signaling is known to mediate the development of anti-GBM glomerulonephritis, we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaomei, Ren, Lu, Yang, Qianqian, Song, Hui, Tang, Qiaoli, Zhang, Mingchao, Zhang, Jiong, Tang, Zheng, Shi, Shaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866651/
https://www.ncbi.nlm.nih.gov/pubmed/35223886
http://dx.doi.org/10.3389/fmed.2022.697443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866651/
https://www.ncbi.nlm.nih.gov/pubmed/35223886
http://dx.doi.org/10.3389/fmed.2022.697443

Ejemplares similares